Drug intelligence / Profile preview

solanocapsine

Development stage
Preclinical
Lead developer
CONICET
Modality
Small Molecules
Administration
Intraperitoneal, Subcutaneous, Intravenous
01

Overview

Solanocapsine is a steroidal alkaloid naturally found in the Jerusalem cherry (*Solanum pseudocapsicum*). It has been identified as a selective synthetic lethal inducer in BRCA2-deficient cancer cells. Chemoproteomic profiling revealed that solanocapsine acts as an inhibitor of deoxycytidine kinase (dCK), a rate-limiting enzyme in the deoxyribonucleoside salvage pathway. By inhibiting dCK, solanocapsine restricts the nucleotide supply during mitosis, selectively triggering cell death in BRCA2-deficient contexts. While solanocapsine itself is a toxic alkaloid, it serves as a chemical starting point for the development of more potent dCK-inhibiting analogs for the treatment of BRCA2-deficient malignancies.

Other names
solanocapsin
02

Targets

AcetylcholinesteraseDCK (Deoxycytidine kinase)

Beyond the preview

Go deeper on solanocapsine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on solanocapsine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call